151 related articles for article (PubMed ID: 36651798)
1. Epicutaneous Immunotherapy with CBir1 Alleviates Intestinal Inflammation.
Chen X; Elson CO; Dunkin D
Inflamm Bowel Dis; 2023 May; 29(5):798-807. PubMed ID: 36651798
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3
Chen X; Berin MC; Gillespie VL; Sampson HA; Dunkin D
Front Immunol; 2021; 12():637630. PubMed ID: 33717186
[No Abstract] [Full Text] [Related]
3. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis.
Feng T; Cao AT; Weaver CT; Elson CO; Cong Y
Gastroenterology; 2011 Jun; 140(7):2031-43. PubMed ID: 21419767
[TBL] [Abstract][Full Text] [Related]
4. Epicutaneous Tolerance Induction to a Bystander Antigen Abrogates Colitis and Ileitis in Mice.
Dunkin D; Berin MC; Mondoulet L; Tobar S; Yeretssian G; Tordesillas L; Iuga A; Larcher T; Gillespie V; Benhamou PH; Colombel JF; Sampson HA
Inflamm Bowel Dis; 2017 Nov; 23(11):1972-1982. PubMed ID: 29019858
[TBL] [Abstract][Full Text] [Related]
5. Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice.
Yang W; Yu T; Cong Y
J Vis Exp; 2021 Dec; (178):. PubMed ID: 34978289
[TBL] [Abstract][Full Text] [Related]
6. Enhanced CBir1-specific innate and adaptive immune responses in Crohn's disease.
Shen C; Landers CJ; Derkowski C; Elson CO; Targan SR
Inflamm Bowel Dis; 2008 Dec; 14(12):1641-51. PubMed ID: 18825772
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.
Targan SR; Landers CJ; Yang H; Lodes MJ; Cong Y; Papadakis KA; Vasiliauskas E; Elson CO; Hershberg RM
Gastroenterology; 2005 Jun; 128(7):2020-8. PubMed ID: 15940634
[TBL] [Abstract][Full Text] [Related]
8. The gut microbiome as a target for regulatory T cell-based immunotherapy: induction of regulatory lymphocytes by oral administration of anti-LPS enriched colostrum alleviates immune mediated colitis.
Ben Ya'acov A; Lichtenstein Y; Zolotarov L; Ilan Y
BMC Gastroenterol; 2015 Oct; 15():154. PubMed ID: 26518263
[TBL] [Abstract][Full Text] [Related]
9. Crohn's Disease Patients Uniquely Contain Inflammatory Responses to Flagellin in a CD4 Effector Memory Subset.
Morgan NN; Duck LW; Wu J; Rujani M; Thomes PG; Elson CO; Mannon PJ
Inflamm Bowel Dis; 2022 Dec; 28(12):1893-1903. PubMed ID: 35931421
[TBL] [Abstract][Full Text] [Related]
10. Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production.
Feng T; Qin H; Wang L; Benveniste EN; Elson CO; Cong Y
J Immunol; 2011 Jun; 186(11):6313-8. PubMed ID: 21531892
[TBL] [Abstract][Full Text] [Related]
11. Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.
Canavan JB; Scottà C; Vossenkämper A; Goldberg R; Elder MJ; Shoval I; Marks E; Stolarczyk E; Lo JW; Powell N; Fazekasova H; Irving PM; Sanderson JD; Howard JK; Yagel S; Afzali B; MacDonald TT; Hernandez-Fuentes MP; Shpigel NY; Lombardi G; Lord GM
Gut; 2016 Apr; 65(4):584-94. PubMed ID: 25715355
[TBL] [Abstract][Full Text] [Related]
12. Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.
Papadakis KA; Yang H; Ippoliti A; Mei L; Elson CO; Hershberg RM; Vasiliauskas EA; Fleshner PR; Abreu MT; Taylor K; Landers CJ; Rotter JI; Targan SR
Inflamm Bowel Dis; 2007 May; 13(5):524-30. PubMed ID: 17260364
[TBL] [Abstract][Full Text] [Related]
13. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.
Radulovic K; Manta C; Rossini V; Holzmann K; Kestler HA; Wegenka UM; Nakayama T; Niess JH
J Immunol; 2012 Feb; 188(4):2001-13. PubMed ID: 22250092
[TBL] [Abstract][Full Text] [Related]
14. Type I IFNs regulate effector and regulatory T cell accumulation and anti-inflammatory cytokine production during T cell-mediated colitis.
Kole A; He J; Rivollier A; Silveira DD; Kitamura K; Maloy KJ; Kelsall BL
J Immunol; 2013 Sep; 191(5):2771-9. PubMed ID: 23913971
[TBL] [Abstract][Full Text] [Related]
15. Gut Inflammation in Mice Triggers Proliferation and Function of Mucosal Foxp3+ Regulatory T Cells but Impairs Their Conversion from CD4+ T Cells.
Boschetti G; Kanjarawi R; Bardel E; Collardeau-Frachon S; Duclaux-Loras R; Moro-Sibilot L; Almeras T; Flourié B; Nancey S; Kaiserlian D
J Crohns Colitis; 2017 Jan; 11(1):105-117. PubMed ID: 27364948
[TBL] [Abstract][Full Text] [Related]
16. Intestinal damage is required for the pro-inflammatory differentiation of commensal CBir1-specific T cells.
Sorini C; Cardoso RF; Tripathi KP; Mold JE; Diaz OE; Holender Y; Kern BC; Czarnewski P; Gagliani N; Villablanca EJ
Mucosal Immunol; 2024 Feb; 17(1):81-93. PubMed ID: 37952848
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease.
Benson JM; Shepherd DM
Toxicol Sci; 2011 Mar; 120(1):68-78. PubMed ID: 21131560
[TBL] [Abstract][Full Text] [Related]
18. T Cell Proliferation and Colitis Are Initiated by Defined Intestinal Microbes.
Chiaranunt P; Tometich JT; Ji J; Hand TW
J Immunol; 2018 Jul; 201(1):243-250. PubMed ID: 29777027
[TBL] [Abstract][Full Text] [Related]
19. Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice.
Dioszeghy V; Mondoulet L; Laoubi L; Dhelft V; Plaquet C; Bouzereau A; Dupont C; Sampson H
Front Immunol; 2018; 9():1951. PubMed ID: 30233572
[TBL] [Abstract][Full Text] [Related]
20. Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models.
Maerten P; Shen C; Colpaert S; Liu Z; Bullens DA; van Assche G; Penninckx F; Geboes K; Vanham G; Rutgeerts P; Ceuppens JL
Clin Exp Immunol; 2004 Feb; 135(2):310-7. PubMed ID: 14738461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
